A hematology blood transfusion hospital in (b)(6) reported six pediatric patients (all ages and genders not provided) with a port-a-cath allegedly experienced skin irritation and possible infection.The hospital reported 1626w 3m¿ tegaderm¿ dressings were applied to protect the port-a-cath on each patient.Clabsi was alleged for two of the children, where a physician replaced the ports.No further details were provided on these two incidents.Open packaging of the tegaderm dressing was also reported.The hospital provided specific details on three patient incidents; a male pediatric patient developed skin redness after application of the referenced dressings to protect a port-a-cath.The alleged skin redness was reportedly 2cm x 2cm in size and occurred inside the dressing area on the chest.The skin redness appeared after 3-4 days of wear of the most recently applied dressing and resolved in one week.A second male pediatric patient developed a skin rash with itching after application of the referenced dressings to protect a port-a-cath.The alleged rash was reportedly 2cm x 2cm in size and occurred inside the dressing area on the upper chest.The rash appeared after 3-4 days of wear of the most recently applied dressing and resolved in one week.A third male pediatric patient developed blisters after application of the referenced dressings to protect a port-a-cath.The alleged blisters were reportedly within a 2cm x 2cm area and occurred inside the dressing area on the upper chest.The blisters appeared after 3-4 days of wear of the most recently applied dressing and resolved in one week.In all three cases the dressings were applied in contact with an open wound.Alcohol was used to prep the skin prior to application.The dressings were applied over a two-week period and were changed once per week.The patients had no known history of skin pathologies, sensitivities or allergies.The patients were changed to a new catheter.No further medical treatment was required.
|